000 | 01932 a2200529 4500 | ||
---|---|---|---|
005 | 20250517181106.0 | ||
264 | 0 | _c20180611 | |
008 | 201806s 0 0 eng d | ||
022 | _a1178-2005 | ||
024 | 7 |
_a10.2147/COPD.S147968 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTsai, Ying-Huang | |
245 | 0 | 0 |
_aTrends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010. _h[electronic resource] |
260 |
_bInternational journal of chronic obstructive pulmonary disease _c2017 |
||
300 |
_a2787-2793 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAmbulatory Care _xtrends |
650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 |
_aDrug Costs _xtrends |
650 | 0 | 4 |
_aEmergency Service, Hospital _xtrends |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHealth Resources _xeconomics |
650 | 0 | 4 |
_aHospital Costs _xtrends |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aPractice Patterns, Physicians' _xeconomics |
650 | 0 | 4 |
_aProcess Assessment, Health Care _xeconomics |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 | _aTaiwan |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aYang, Tsung-Ming | |
700 | 1 | _aLin, Chieh-Mo | |
700 | 1 | _aHuang, Shu-Yi | |
700 | 1 | _aWen, Yu-Wen | |
773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 12 _gp. 2787-2793 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S147968 _zAvailable from publisher's website |
999 |
_c27679112 _d27679112 |